[HTML][HTML] RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner

X Guo, K Li, W Jiang, Y Hu, W Xiao, Y Huang, Y Feng… - Molecular cancer, 2020 - Springer
Abstract Background N6-methyladenosine (m6A) is the most abundant reversible
methylation modification of eukaryotic mRNA, and it plays vital roles in tumourigenesis. This …

RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner

X Guo, K Li, W Jiang, Y Hu, W Xiao… - Molecular …, 2020 - pubmed.ncbi.nlm.nih.gov
Background N6-methyladenosine (m6A) is the most abundant reversible methylation
modification of eukaryotic mRNA, and it plays vital roles in tumourigenesis. This study aimed …

[PDF][PDF] RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner

X Guo, K Li, W Jiang, Y Hu, W Xiao, Y Huang, Y Feng… - 2020 - scholar.archive.org
Abstract Background: N6-methyladenosine (m6A) is the most abundant reversible
methylation modification of eukaryotic mRNA, and it plays vital roles in tumourigenesis. This …

[HTML][HTML] RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner

X Guo, K Li, W Jiang, Y Hu, W Xiao… - Molecular …, 2020 - molecular-cancer.biomedcentral …
N6-methyladenosine (m6A) is the most abundant reversible methylation modification of
eukaryotic mRNA, and it plays vital roles in tumourigenesis. This study aimed to explore the …

[HTML][HTML] RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner

X Guo, K Li, W Jiang, Y Hu, W Xiao, Y Huang… - Molecular …, 2020 - ncbi.nlm.nih.gov
Background N6-methyladenosine (m6A) is the most abundant reversible methylation
modification of eukaryotic mRNA, and it plays vital roles in tumourigenesis. This study aimed …

RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner.

X Guo, K Li, W Jiang, Y Hu, W Xiao… - Molecular …, 2020 - search.ebscohost.com
Abstract Background: N6-methyladenosine (m6A) is the most abundant reversible
methylation modification of eukaryotic mRNA, and it plays vital roles in tumourigenesis. This …

RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner.

X Guo, K Li, W Jiang, Y Hu, W Xiao, Y Huang… - Molecular …, 2020 - go.gale.com
Background N6-methyladenosine (m6A) is the most abundant reversible methylation
modification of eukaryotic mRNA, and it plays vital roles in tumourigenesis. This study aimed …

RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner

X Guo, K Li, W Jiang, Y Hu, W Xiao, Y Huang… - Molecular …, 2020 - search.proquest.com
Background N6-methyladenosine (m6A) is the most abundant reversible methylation
modification of eukaryotic mRNA, and it plays vital roles in tumourigenesis. This study aimed …

RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner.

X Guo, K Li, W Jiang, Y Hu, W Xiao, Y Huang… - Molecular …, 2020 - europepmc.org
Background N6-methyladenosine (m6A) is the most abundant reversible methylation
modification of eukaryotic mRNA, and it plays vital roles in tumourigenesis. This study aimed …

RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner.

X Guo, K Li, W Jiang, Y Hu, W Xiao, Y Huang… - Molecular …, 2020 - europepmc.org
Background N6-methyladenosine (m6A) is the most abundant reversible methylation
modification of eukaryotic mRNA, and it plays vital roles in tumourigenesis. This study aimed …